IL6 and COVID-19: To combat the cytokine storm in patients with COVID-19, several anti-rheumatic medicines, chloroquine, hydroxychloroquine, as well as JAK inhibitors, IL-6 inhibitors, IL-1 inhibitors, anti-TNF-α agents, and corticosteroids are considered [59].